PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib

PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib

Multiple myeloma (MM), the second most commonly diagnosed hematologic neoplasm, is the most significant clinical manifestation in a series of plasma cell (PC) dyscrasia. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM), approximately 1% or 10% of which, respectively,...

Full description

Bibliographic Details
Main Authors: Dong Wu, Jiyu Miao, Jinsong Hu, Fangmei Li, Dandan Gao, Hongli Chen, Yuandong Feng, Ying Shen, Aili He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
proteasome inhibitor
PSMB7
WGCNA
drug resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.684232/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.684232/full

Similar Items